Can You Take Estrogen Without Progesterone? The Answer Depends on One Organ

Why do you need progesterone with estrogen?

Progesterone's job in an HRT regimen is endometrial protection. Systemic estrogen, whether from a pill, patch, gel or pellet, stimulates the lining of the uterus to grow. Unchecked, that growth becomes endometrial hyperplasia, which the estradiol label describes as a condition that "may be a precursor to endometrial cancer." Progesterone opposes the growth. That is the reason the second prescription exists, and it is why the requirement vanishes when the uterus does.

The size of the protection is printed on the Prometrium label, the FDA-approved micronized progesterone capsule (NDA 019781). In a randomized, double-blind trial of 358 postmenopausal women with a uterus treated for up to 36 months, endometrial hyperplasia or worse was found in 64% of the arm taking conjugated estrogens alone, against 6% of the arm taking the same estrogen plus cyclical progesterone 200 mg, with a placebo arm at 3%. We publish the label's full table, arm sizes and all five diagnosis rows included, on the progesterone hub, so this page will leave it at the headline pair: 64 against 6.

The clinical guidance says the same thing the label does. The Menopause Society's 2022 hormone therapy position statement states that women with an intact uterus using systemic estrogen should receive adequate progestogen, with one named exception we cover below (conjugated estrogens with bazedoxifene), and adds that when adequate progestogen is combined with systemic estrogen, the risk of endometrial neoplasia "is not higher than in untreated women." Protection, correctly dosed, closes the gap the estrogen opens. Progesterone's own side effects are a separate ledger, and we keep that table on its own page.

What happens if you take estrogen alone with a uterus?

The estradiol label answers this with numbers, in its warnings section on malignant neoplasms, and they are worth reading before deciding the second pill is optional. Here is what the label reports, exactly as scoped:

Two honest readings of that table. First, a missed refill is a phone call: the label reports most studies show no significant increase under a year of use. Second, a standing decision to run systemic estrogen unopposed for years multiplies a cancer risk by double digits, and the exposure keeps counting after you stop. The Menopause Society adds that progestogen taken "continuously or cyclically for 10 to 14 days monthly significantly reduces this risk," so the protective schedule has a defined shape.

Do you need progesterone after a hysterectomy?

Generally no, and this is the half of the fork the internet keeps hedging for no reason. The label sentence is five words longer than it needs to be: "a woman without a uterus does not need progestin." The logic is the same mechanism run backwards. Progesterone in this regimen protects the endometrium, and after a hysterectomy there is no endometrium to protect.

Estrogen alone after hysterectomy is also one of the best-studied regimens in menopausal medicine. The Women's Health Initiative estrogen-alone trial randomized 10,739 postmenopausal women aged 50 to 79, every one of them with a prior hysterectomy, to conjugated estrogens or placebo. Its cardiovascular and breast findings are their own story, one our safety flagship walks through; the point here is the population itself: estrogen alone is the studied regimen for women without a uterus. Note what the rule keys on: the uterus, and only the uterus. Whether your ovaries were kept or removed changes your symptoms and your dosing conversation, and changes nothing about whether a progestogen is required.

The exception the label names is residual endometriosis. The estradiol label's precautions record that "a few cases of malignant transformation of residual endometrial implants have been reported in women treated post-hysterectomy with estrogen alone therapy," and instruct that for patients known to have residual endometriosis after hysterectomy, "the addition of progestin should be considered." Endometrial tissue left behind outside the uterus can respond to estrogen the way the lining did. If your hysterectomy was for endometriosis, say so at intake and expect the progestogen question to come back. Women in peri with a uterus still in place are on the other side of the fork entirely.

When is estrogen without progesterone okay even with a uterus?

Three narrow cases, each with a named source, and none of them is "my prescriber didn't mention it."

The vaginal estrogen row deserves its qualifier spelled out, since it covers a lot of women. The position statement's wording is that a progestogen is "generally not indicated" at the recommended low doses for genitourinary symptoms, and the same sentence concedes that "clinical trial data supporting endometrial safety beyond 1 year are lacking." Low dose and local route earn the exemption; a vaginal product dosed high enough to treat hot flashes is systemic therapy wearing a different label. The last two rows stay exactly as the statement grades them: endometrial protection suggested in studies up to 2 years for the bazedoxifene combination, and off-label with limited trial data for the hormonal IUD. Every row is a conversation with a prescriber, and the table is what that conversation should sound like.

When should you take progesterone, morning or night?

Night, and the label is unusually direct about why. The Prometrium label instructs a "single daily dose at bedtime" and warns that the capsules "may cause transient dizziness and drowsiness," with caution advised when driving or operating machinery. The patient information goes further: some women "may experience extreme dizziness and/or drowsiness during initial therapy," with blurred vision and difficulty walking on the reported list. Oral micronized progesterone is a sedating drug for a meaningful fraction of the women who take it, and bedtime dosing is how the label routes that effect somewhere harmless.

If sleep has been the enemy for a year, that drowsiness reads like a feature. The label still files it under warnings: a side effect that lands at a convenient hour is still a side effect, so judge it as one.

On schedule: the regimen on the Prometrium label for a postmenopausal woman with a uterus on daily conjugated estrogens is 200 mg at bedtime for 12 days sequentially per 28-day cycle. The Menopause Society's statement points the same way, giving 200 mg per day for 12 to 14 days per month as its example of adequate oral micronized progesterone dosing, and notes that continuous and cyclic progestogen schedules both significantly reduce the endometrial risk. Which schedule you get shapes whether you see a monthly bleed, so ask before the first refill rather than after the first surprise. Our dosage chart lays out the standard regimens side by side, and the full guide places progesterone inside the whole regimen decision.

Can you take progesterone if you're allergic to peanuts?

Prometrium, no. The label lists it under contraindications: the capsules contain peanut oil and are contraindicated in patients allergic to peanuts. The patient leaflet on the same label says it plainest: "This product contains peanut oil and should not be used if you are allergic to peanuts." Peanut oil is in the inactive-ingredient list of both capsule strengths, 100 mg and 200 mg. A contraindication is the label's strongest category, and it applies however mild your last reaction was.

What it means in practice: tell every prescriber about the allergy before the progesterone conversation starts, and check the inactive-ingredient list of the exact product you are dispensed, because generic progesterone capsules can also contain peanut oil (the Northstar Rx generic label on DailyMed lists it, checked August 2026). Alternatives are a prescriber decision: synthetic progestins are different molecules with different formulations, and the tradeoffs are the entire subject of our progesterone vs progestin comparison. Compounded progesterone is the other path telehealth platforms offer, and it carries its own asterisk: no compounded drug product goes through FDA approval, a distinction our bioidentical HRT guide unpacks.

Did the 2026 label change end the progesterone rule?

No. This is the confusion of the year, so here is the clean separation. The boxed-warning removal the FDA announced in November 2025 and approved in February 2026 concerned the cardiovascular disease, breast cancer and probable dementia statements that systemic HRT labels had carried since the Women's Health Initiative era. What changed and what it means is its own article, and the black box guide tracks the label-by-label rollout. The endometrial rule sits outside all of it: the instruction to add a progestin for a woman with a uterus lives in the dosage section, and unopposed estrogen's endometrial cancer risk was never among the statements removed.

A detail from our own checking that makes the point concrete: the Teva estradiol tablets label posted on DailyMed, version effective February 2024 and still the posted version when we verified in August 2026, opens its boxed warning with the heading "ESTROGENS INCREASE THE RISK OF ENDOMETRIAL CANCER." Manufacturers repost labels on their own schedule after an FDA-approved change, which is why you can still find the old box on live labels today, and why the HRT timeline is worth a look before arguing with a pharmacist about what a label currently says. Whenever that label is reposted with the 2026 revisions, expect the endometrial guidance to survive the edit.

How do you get the estrogen plus progesterone combination prescribed right?

The fork gives you a three-question test for any telehealth platform, and it takes two minutes at intake. Did they ask whether you have a uterus? A platform that reaches checkout on systemic estrogen without asking has failed the most basic screen in this field. Did they name the molecule? Micronized progesterone and a synthetic progestin are different drugs with different evidence, and "we include a progestogen" without naming which is a transparency problem. Did they state the regimen? You should know before paying whether you are on continuous or cyclic dosing and what that means for bleeding.

We track which platforms dispense progesterone, which name the molecule in their published formulary, and what each one charges, in the priced table on our progesterone hub. For choosing the platform itself, start from the rankings, or take the two-minute match quiz if you want the shortlist filtered to your situation, and see how to get HRT online for the intake-to-prescription mechanics. Every score on those pages follows the published methodology, and affiliate status never moves a score.